Works matching IS 03624803 AND DT 2024 AND VI 67 AND IP 11
Results: 4
Preliminary Research of Radiolabeled Atezolizumab for the Noninvasive Evaluation of TNBC PD‐L1 Expression In Vivo.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 384, doi. 10.1002/jlcr.4122
- By:
- Publication type:
- Article
Lead‐212/Bismuth‐212 In Vivo Generator Based on Ultrasmall Silver Telluride Nanoparticles.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 375, doi. 10.1002/jlcr.4121
- By:
- Publication type:
- Article
<sup>68</sup>Ga Radiolabeling of NODASA‐Functionalized Phage Display–Derived Peptides for Prospective Assessment as Tuberculosis‐Specific PET Radiotracers.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 360, doi. 10.1002/jlcr.4120
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 357, doi. 10.1002/jlcr.4040
- Publication type:
- Article